Dier Mardi

CIK 00015745917 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001574591

Recent Transactions

50 trades

Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2026-01-02+40,000→ 40,000 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$574.00/sh−717→ 12,812 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$570.39/sh−320→ 14,293 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$573.02/sh−354→ 13,529 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$596.18/sh−80→ 10,440 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$576.15/sh−240→ 12,452 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$571.99/sh−410→ 13,883 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$578.83/sh−258→ 11,874 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$589.65/sh−160→ 10,754 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$595.20/sh−74→ 10,520 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$574.95/sh−120→ 12,692 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-12-02−4,173→ 9,180 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$579.85/sh−480→ 11,394 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-02$251.63/sh+4,173→ 14,613 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2025-06-12+38,000→ 38,000 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-10$323.04/sh−258→ 10,440 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05+3,784→ 10,698 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-03-05+6,374→ 6,374 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-03$323.54/sh−774→ 6,914 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-03$325.89/sh−1,187→ 7,688 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2025-01-02+35,000→ 35,000 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2024-06-14+23,500→ 23,500 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2024-06-12+25,600→ 25,600 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2023-06-16+23,500→ 23,500 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2023-06-14+20,500→ 20,500 total
Other
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2023-05-09+85,226→ 85,226 total
Other
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2023-05-09+673,621→ 673,621 total
Purchase
ACELYRIN, Inc.
Common Stock
2023-05-09$18.00/sh+5,556→ 5,556 total
Purchase
ACELYRIN, Inc.
Common Stock
2023-05-09$18.00/sh+875→ 875 total
Purchase
ACELYRIN, Inc.
Common Stock
2023-05-09$18.00/sh+875→ 875 total
Other
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2023-05-09−673,621→ 0 total
Other
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2023-05-09−85,226→ 0 total
Award
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2023-05-04+85,226→ 85,226 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-10-14$40.16/sh−1,629→ 66,695 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-10-12$38.22/sh−3,484→ 68,324 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-09-16+20,000→ 71,808 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2022-06-17+34,300→ 34,300 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2022-06-17+53,700→ 53,700 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-03$64.55/sh−420→ 51,808 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2022-03-01+24,900→ 24,900 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-01+14,000→ 52,228 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-01$66.62/sh−534→ 38,228 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-10-14$81.16/sh−3,261→ 38,762 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-10-12$82.79/sh−3,477→ 42,023 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2021-06-18+23,344→ 23,344 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2021-06-16+16,625→ 16,625 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2021-06-02+5,000→ 10,000 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-06-02+10,000→ 10,000 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-03-01+5,500→ 45,500 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2021-03-01+11,000→ 11,000 total

Companies

Recent Filings

Address

C/O ORIC PHARMACEUTICALS, INC. 240 E. GRAND AVE., 2ND FLOOR

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov